2020 Conference Announcement
Professor and Chair, Department of Pharmaceutical Sciences
University of South Florida, USA
Director, Settlement Clinic
Assistant Professor, Department of Pharmacology
University of Athens Medical School, Greece
Submit manuscript at www.longdom.org/submissions/pharmacogenomics-pharmacoproteomics.html or send as an e-mail attachment to the Editorial Office at [email protected]
NLM ID: 101575137
Index Copernicus Value 79.65
The Journal of Pharmacogenomics & Pharmacoproteomics publishes articles on new innovations in the field of personalized medicines. The original research articles or current reviews published under the journal deals with the influence of genetic variations on drug response in patients and viceversa. The journal aims to publish innovations in customized drug discovery using proteome technology. The journal provides an open access platform to publish latest advancements in the field of drug design, drug development and drug delivery.
Journal of Pharmacogenomics & Pharmacoproteomics is an open access and peer reviewed journal includes a wide range of field in its discipline to create a platform for the authors to make their valuable contributions towards the journal and the peer review process promises the publishing of quality, reliable and important articles for the readers and authors of scholarly, academic and scientific field.
The Pharmacogenomics & Pharmacoproteomics Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members Pharmacogenomics & Pharmacoproteomics journal impact factor is mainly calculated based on the number of articles that undergo a single blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Pharmacogenomics and Pharmacoproteomics Open Access Journals are freely accessible to everyone immediately after publication.